Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E2 concentrations
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Veterinary Pharmacology and Therapeutics"
DOI: 10.1111/jvp.12464
Abstract: In equids, phenylbutazone at high doses induces gastric disease, primarily in the glandular portion of the stomach. However, the mechanism of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric disease in horses has yet to be determined. While… read more here.
Keywords: phenylbutazone; gastric disease; glandular gastric; treatment ... See more keywords